Schiff Andrew N
SEC-identified person · CIK 1172252 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Monte Rosa Therapeutics, Inc. GLUE | Director | filed 2021 - 2026 |
| Aclaris Therapeutics, Inc. ACRS | Director | filed 2017 - 2026 |
| Elevation Oncology, Inc. ELEV | Officer | filed 2021 - 2023 |
| Zosano Pharma Corp ZSAN | Officer | filed 2018 - 2019 |
| Viracta Therapeutics, Inc. VIRX | Officer | filed 2019 - 2019 |
| Loxo Oncology, Inc. LOXO | Officer | filed 2014 - 2018 |
| Zeltiq Aesthetics Inc ZLTQ | Director | filed 2011 - 2017 |
| Syros Pharmaceuticals, Inc. SYRS | Officer | filed 2016 - 2016 |
| Agile Therapeutics INC AGRX | Director | filed 2014 - 2016 |
| Viewray, Inc. VRAY | Officer | filed 2016 - 2016 |
| Transenterix, INC. TRXC.OB | Director | filed 2013 - 2016 |
| T2 Biosystems, Inc. TTOO | Officer | filed 2014 - 2015 |
| Esperion Therapeutics, Inc. ESPR | Officer | filed 2013 - 2015 |
| Cidara Therapeutics, Inc. CDTX | Officer | filed 2015 - 2015 |
| Versartis, Inc. VSAR | Officer | filed 2014 - 2015 |
| Durata Therapeutics, Inc. DRTX | Officer | filed 2012 - 2014 |
| R&R Acquisition VI, INC ADMA | Officer | filed 2012 - 2013 |
| Melinta Therapeutics, INC. /NEW/ MLNT | Officer | filed 2012 - 2012 |
| Interpharm Holdings INC IPA | Officer | filed 2007 - 2008 |
| Planet Technologies, INC PLNT | Director | filed 2007 - 2007 |
| Tenby Pharma INC N/A | Director | filed 2007 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.